‘We made 434pc on one stock – now we’re hunting for the next Ozempic’
Fund Of The Week quizzes fund managers about how they’re investing your money. If you’d like to suggest which funds you want ...
Valeo Financial Advisors LLC Buys Shares of 385 argenx SE (NASDAQ:ARGX)
Valeo Financial Advisors LLC bought a new stake in argenx SE (NASDAQ:ARGX – Free Report) during the 4th quarter, according to ...
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 18, 2025 Halozyme Therapeutics, Inc. beats earnings expectations. Reported EPS is ...
Q4 2024 Halozyme Therapeutics Inc Earnings Call
Helen Torley; President, Chief Executive Officer, Director; Halozyme Therapeutics Inc Nicole Labrosse; Chief Financial Officer, Senior Vice President; Halozyme Therapeutics Inc Good afternoon. My name ...
Halozyme projects $1.15B-$1.225B revenue for 2025 with growth from key products
Halozyme Therapeutics' record-breaking 2024 revenue exceeded $1B, with strong 2025 growth projections led by DARZALEX & VYVGART.